Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Thyroid. 2013 Aug;23(8):982-8. doi: 10.1089/thy.2012.0297.
Monitoring changes in the thyroid bed (TB) is one of the clinical mainstays for surveillance of recurrent thyroid carcinoma. Fine-needle aspiration (FNA) is a diagnostic tool that is commonly used to aid in the identification of residual or recurrent disease. The aim of our study was to evaluate the efficacy of ultrasound-guided FNA of the TB in detecting recurrent thyroid cancer and to correlate the findings with clinicopathologic parameters to identify predictors of TB recurrence.
We retrieved cases of soft tissue masses within the TB that were evaluated for recurrence between January 1, 2006, and February 1, 2011. All ultrasound-guided FNA biopsies clinically suspected to indicate a lymph node metastasis and specimens with lymphocytes were excluded from the data.
Of the 291 patients identified for evaluation of recurrence, 250 had papillary thyroid carcinoma (PTC), 10 had follicular carcinoma, 22 had medullary carcinoma, 7 had Hürthle cell carcinoma, and 2 had a previous thyroidectomy for an unknown type of thyroid carcinoma. For all FNAs that were clinically suspicious or intermediate for recurrence, the rate of positivity was 71.8% (209 patients). All cases diagnosed as "positive for PTC" or "suspicious for PTC" on TB FNA were found to have soft tissue metastasis on follow-up surgical resection. This resulted in a negative predictive value of 88.4% and a positive predictive value of 100%. The average time between thyroidectomy and TB FNA was 73.5 months. Of the patients with a previous diagnosis of PTC, those with suspicious/positive cytology were more likely to be women, to be older at thyroidectomy, to have documented metastasis to other sites as well as extrathyroidal extension and multifocal primary disease as compared with nondiagnostic/negative cytology cases. Patient age ≥45 years, primary tumor size at thyroidectomy, and surgical resection margin status had no statistical significance for predicting risk of TB recurrence.
TB recurrence of PTC is most likely to occur in patients who have the following clinicopathologic parameters: documented metastasis to any site, extrathyroidal extension, and increased number of primary cancer foci.
监测甲状腺床(TB)的变化是监测复发性甲状腺癌的临床基础之一。细针穿刺(FNA)是一种常用的诊断工具,用于辅助识别残留或复发性疾病。我们的研究目的是评估超声引导下 TB FNA 检测复发性甲状腺癌的疗效,并将发现与临床病理参数相关联,以确定 TB 复发的预测因素。
我们检索了 2006 年 1 月 1 日至 2011 年 2 月 1 日期间因复发而评估的 TB 内软组织肿块病例。所有临床怀疑为淋巴结转移的超声引导 FNA 活检和含有淋巴细胞的标本均被排除在数据之外。
在 291 例评估复发的患者中,250 例为甲状腺乳头状癌(PTC),10 例为滤泡状癌,22 例为髓样癌,7 例为 Hurthle 细胞癌,2 例为甲状腺切除术用于未知类型的甲状腺癌。对于所有临床可疑或中间复发的 FNA,阳性率为 71.8%(209 例)。所有在 TB FNA 中诊断为“PTC 阳性”或“PTC 可疑”的病例在随访手术切除时均发现软组织转移。这导致阴性预测值为 88.4%,阳性预测值为 100%。甲状腺切除术与 TB FNA 之间的平均时间为 73.5 个月。在既往诊断为 PTC 的患者中,细胞学可疑/阳性的患者更可能为女性,甲状腺切除术时年龄较大,与细胞学非诊断/阴性病例相比,有其他部位转移、甲状腺外延伸和多灶性原发性疾病的记录。患者年龄≥45 岁、甲状腺切除术时的原发肿瘤大小以及手术切缘状态对预测 TB 复发风险无统计学意义。
PTC 的 TB 复发最有可能发生在具有以下临床病理参数的患者中:任何部位的转移记录、甲状腺外延伸和原发性癌症病灶数量增加。